Single-dose Pharmacokinetics and Safety of Oral Lofexidine in Renally-Impaired Subjects

NCT02313103 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Renally Impaired Subjects

Interventions

DRUG: lofexidine HCl

Sponsor

USWM, LLC (dba US WorldMeds)

Collaborators

[object Object]